On Monday 25 June, the US Food and Drug Administration (FDA) approved the new cannabis-based medicine Epidiolex for use in Lennox-Gastuat syndrome (LGS) and Dravet syndrome.
Update 22 June 2018
Lamotrigine Teva 100mg tablets (non-dispersible) have just come back in stock.
The 50mg non-dispersible tablets are still out of stock. Teva does not currently know when these will be back in stock.
Original story 8 June 2018
Teva is out of stock of the following medicines:
• Lamotrigine Teva 100 mg tablets (non-dispersible)
• Lamotrigine Teva 50 mg tablets (non-dispersible)
Teva does not currently know when these will be back in stock. We'll update this page when we know more.
A review into the use of medicinal cannabis was announced by the Home Office yesterday at the House of Commons.
Home Secretary, Sajid Javid, made the announcement saying that the “position we find ourselves in is not satisfactory”.
The UK Home Office has returned 12-year-old Billy Caldwell’s cannabis oil epilepsy medicine after he was taken to hospital on Friday 15 June. This was after Billy’s medicine was confiscated at Heathrow Airport on Monday 11 June.
Billy, from Castlederg in Northern Ireland, has a severe form of epilepsy and has previously had up to 100 seizures a day.
Maxine has Dravet syndrome, a rare and severe form of epilepsy. Her mum Patricia tells Epilepsy Today about life with the condition, from diagnosis and treatments, to finding independence
A UK Competition Appeal Tribunal has overturned the decision to fine two pharmaceutical companies over price hikes of their phenytoin sodium capsules.
Rosemont has stopped making its version of phenytoin oral suspension.
If you take this version of phenytoin, you’ll need to switch to another manufacturer’s version. If you have any concerns about this, speak to your doctor, epilepsy nurse or pharmacist.
The Belfast Trust has called in 2,500 patients for a review after an investigation into the work of a consultant neurologist.
Concerns were raised about Dr Michael Watt’s treatment plans and diagnoses by other doctors. After this, his work was investigated by the trust and the Royal College of Physicians.
This resulted in 2,500 people who received treatment from Dr Watt being asked to come in for a review. They were being treated for a number of conditions, including epilepsy and MS.
An inquest into the death of a 36-year-old man with epilepsy found that he died of natural causes.
Danny Tozer had epilepsy, autism and a learning disability. He was a resident at a supported living home when, in 2015, he died after having a seizure. The coroner concluded that Danny died from sudden unexpected death in epilepsy (SUDEP).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today changed the licence for valproate medicines in the UK.
Sodium valproate must no longer be prescribed to women or girls of childbearing potential unless they are on the pregnancy prevention programme (PPP).
